Nucleic Acid-based Molecular Treatment of Allergy

ISSN: 1875-614X (Online)
ISSN: 1871-5230 (Print)


Volume 15, 3 Issues, 2016


Download PDF Flyer




Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry

Formerly: Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents

This journal supports open access

Aims & ScopeAbstracted/Indexed in


Submit Abstracts Online Submit Manuscripts Online

Editor-in-Chief:
Claudiu T. Supuran
Neurofarba Department
University of Florence
Florence
Italy


View Full Editorial Board

Subscribe Purchase Articles Order Reprints


Nucleic Acid-based Molecular Treatment of Allergy



Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, 3(1): 63-73.

Author(s): Katarzyna Grzela, Maciej Lazarczyk and Tomasz Grzela.

Affiliation: Molecular Cell Biology Laboratory at the Department of Histology and Embryology, Biostructure Research Center of Warsaw Medical University, Poland

Abstract

The pathogenesis of allergy remains unclear. Therefore the standard treatment is mainly focused on reduction of clinical sympthoms of hypersensitivity reaction without eliminating the cause of that. Moreover, being multidirectional and unselective, such treatment affects quite frequently tissues not involved in allergic reactions and thus it could result in numerous adverse effects. The most popular hypothesis concerning pathogenesis of allergy assumes a pivotal role of some abnormalities in immunoregulatory cytokines network. Thus, it is obvious that major goal of causal allergy treatment should be restoration of cytokine balance. The recent advances in genetic engineering enabled creation of new treatment strategies also in allergy. Therefore, numerous studies concerning molecular therapy of allergic diseases have been undertaken. The most recent therapeutical approaches, including antisense oligonucleotides, RNA interference technology and gene therapy in allergy treatment have been detaily discussed in this review. Despite the fact that many of these topic methods are still in the trial phase, we suppose they will become a clinical reality in the near future.

Keywords:

allergy, antisense oligonucleotides, cpg motifs, gene therapy, rna interference.



Download Free Order Reprints Order Eprints Rights and Permissions




Article Details

Volume: 3
Issue Number: 1
First Page: 63
Last Page: 73
Page Count: 11
DOI: 10.2174/1568014043483553
Advertisement

Related Journals




Webmaster Contact: urooj@benthamscience.org Copyright © 2016 Bentham Science